Educational information, not medical advice — ask your doctor or midwife.
Kanchanar Guggul is one of Ayurveda's most respected classical formulas, first described in ancient texts like Sharangdhara Samhita. It combines the bark of the Kanchanar tree (Bauhinia variegata) — long prized for reducing lumps and swellings — with Guggul resin, which is known for its powerful anti-inflammatory and metabolic-supporting properties. The formula also includes digestive herbs like Trikatu and Triphala to help the body absorb and use the active compounds effectively.
Kanchanar bark is believed to work primarily on the lymphatic system, helping reduce excess tissue growth and clear blocked channels in the body. Guggulsterones from the Guggul resin have been shown to support thyroid hormone production and reduce inflammation. Together, the formula is thought to regulate cell growth, reduce swelling, and improve the clearance of metabolic waste — which Ayurveda calls 'ama.'
Traditional vati tablets are the most authentic and commonly used form, taken with warm water or milk. Capsules contain powdered or extracted ingredients and are convenient for modern use. Powder form allows flexible dosing but has a strong bitter taste. Most classical texts and Ayurvedic practitioners recommend the tablet or capsule form.
Kanchanar Guggul has been a cornerstone of Ayurvedic medicine for over a thousand years, primarily referenced in Sharangdhara Samhita (13th century CE). It was historically the go-to formula for what Ayurveda called 'granthi' (knots or cysts), 'apachi' (lymph node swellings), and thyroid-related conditions. Its use spans diverse Ayurvedic clinical traditions across India, remaining one of the most prescribed classical formulas in modern Ayurvedic practice today.
Evidence grades and traditional-use labels are explained in our methodology. Nothing here is medical advice.
What it is typically used for, usual dose, cautions, and the study behind it where real trial data exists.
One email with the summary. We'll also send a short weekly evidence update — unsubscribe any time.